IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Indegene IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 1841.76 Cr. The company is based in Bangalore and caters to Pharmaceutical sector. Citigroup Global Markets India , J.P. Morgan India , Kotak Mahindra Capital Company , Nomura Financial Advisory And Securities (India) are the merchant bankers of Indegene IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 14th December 2022.
Indegene IPO open date is 6th May 2024 and close date is 8th May 2024. IPO Allotment Date is 9th May 2024 and Listing date is 13th May 2024.
IPO
Size:
₹ 1841.76 Cr.
Avg IPO Size (Sector Based)
: ₹
1,342.04 cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Citigroup Global
IPO by BRLM so far:
71
City:
Bangalore
IPO so far:
44
Revenue (annualised):
₹
2626.33
cr. 
PE
Ratio:
33.53x
Average Sector PE Ratio: 25.12x
Indegene IPO size is ₹ 1841.76 Cr. with IPO price of ₹ 452.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Citigroup Global Markets India Private Limited is the book-running lead manager of the Indegene IPO. Link Intime India Private Limited is the Registrar for Indegene IPO.
Indegene IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Indegene IPO, based in Bangalore, operates in the Pharmaceutical sector with a focus on digital-led commercialization services for the life sciences industry. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Indegene IPO size is ₹ 1841.76 Cr. with fresh issue size of ₹ 760.00 Cr. and Offer for sale being ₹ 1081.76Cr.
The IPO allotment date for Indegene IPO is expected to be 9th May 2024, after the finalization of basis of allotment. Investors can check Indegene IPO allotment status on the registrars website, Link Intime India Private Limited . Indegene IPO refund dates are 10th May 2024.
Indegene IPO is expected to be listed on 13th May 2024.
The upper price band for the Indegene IPO is set at ₹ 452.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Indegene IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Indegene IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 8th May 2024. After submission, funds are blocked until the basis of allotment of Indegene IPO is finalised.
The merchant banker for Indegene IPO is Citigroup Global Markets India Private Limited , J.P. Morgan India Private Limited , Kotak Mahindra Capital Company Limited , Nomura Financial Advisory And Securities (India) Private Limited . Citigroup Global Markets India Private Limited , J.P. Morgan India Private Limited , Kotak Mahindra Capital Company Limited , Nomura Financial Advisory And Securities (India) Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Indegene IPO RHP for further details.
The registrar for Indegene IPO is Link Intime India Private Limited . Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Indegene IPO through their official website or helpline.
Indegene IPO was subscribed 70.30 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 1841.76 Cr.
Avg IPO Size (Sector Based)
:
₹ 1,342.04 Cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Citigroup Global
IPO by BRLM so far:
71
City:
Bangalore
IPO so far:
44
Revenue (annualised):
₹ 25.33 cr.
PE
Ratio:
33.53x
Average Sector PE Ratio: 25.12x
Indegene IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Indegene Financial Review Page
Indegene IPO subscription was 70.30 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Indegene IPO listed at a listing price of 570.65 against the offer price of 452.00.
The current market price of Indegene is 581.60.
Why Us?
